Canada: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Legal Readiness For Food Producers : Navigating Wittington Investments' C$100M Fund

Wittington Investments, the Weston family's holding company, recently announced a C$100 million fund to support Canadian food producers.

Canada Healthcare

BJ

Bennett Jones LLP

British Columbia Introduces Vaping Cost Recovery Legislation (Bill 24)

British Columbia has introduced new cost recovery legislation: Bill 24, the Vaping Product Damages and Health Care Costs Recovery Act (the "Vaping Cost Recovery Act").

Canada Healthcare

MT

McCarthy Tétrault LLP

Growing Protection For Plant Varieties: Changes Coming To Canada's Plant Breeders' Rights Regulations

The Canadian Food Inspection Agency (CFIA) published proposed amendments to the Plant Breeders' Rights Regulations (PBR Regulations), initiating a public consultation period that will close on October 18, 2025.

Canada Healthcare

TL

Torys LLP

PM(NOC) Regulations: Eighth-year Anniversary Of Major Amendments

September 21, 2025, marked the eighth anniversary of the significant amendments to the Patented Medicines (Notice of Compliance) Regulations (Regulations).

SB

Smart & Biggar

Close Cull: SCC Stays Cull Of Ostrich Farm Exposed To Avian Flu

Canada Healthcare

C

Cassels

Medical Devices Updates: New Health Canada Guidance For Determining Medical Device Application Type And Medical Devices Directorate Performance Reports Released

Canada Healthcare

SB

Smart & Biggar

OTC Brand Names: Balancing Consumer Appeal And Legal Risk

ML

McMillan LLP

Health Canada And The Public Health Agency Of Canada Report On Red Tape Reduction Measures

Canada Healthcare

GW

Gowling WLG

Legislative Update Report No. 2025-18 Le Bulletin d'actualités législatives

Canada Healthcare

OH

Osler, Hoskin & Harcourt LLP

Removal Of Regulatory Exemptions May Expand Food Additives Class, Create Uncertainty.

Canada Healthcare

GW

Gowling WLG

Health Canada Aims To Reduce Red Tape By Increasing International Collaboration, Alignment And Reliance

Canada Healthcare

SB

Smart & Biggar

8 Tips For Maximizing The Sale Of Your Food And Beverage Business

Canada Commercial

BC

Blake, Cassels & Graydon LLP

Drone Use In Agriculture Requires Understanding The Rules

Canada Real Estate

MA

MLT Aikins LLP

A New Era: Health Canada Signals Modernization In Policy And Regulatory Reform

Canada Healthcare

BL

Borden Ladner Gervais LLP

Navigating Climate Challenge: Key Themes For Business At New York Climate Week

Canada Environment

GW

Gowling WLG

Hot Topics, Big Shifts: Five Key Employment Law Developments From Summer 2025

Canada Employment

D

Dentons Canada LLP

End Of The [Rail]Road: CN Plans To Discontinue Former BC Rail Line

Canada Transport

ML

McMillan LLP

Ontario Court Of Appeal Upholds Certification Of Class Proceeding On Behalf Of Cryptocurrency Traders: Confirms That The Novelty And Inherent Risk Of Such Financial Instruments Necessitates Adequate & Timely Disclosure

Canada Technology

DA

DMG Advocates

Regulating Deepfakes Through Copyright: Would Denmark's Proposed Approach Be Right For Canada?

MT

Miller Thomson LLP

Contaminated Cooling Towers Cause Multiple Outbreaks Of Legionnaires' Disease In London, Ontario

Cooling towers contaminated with Legionella bacteria at a Sofina Foods Ltd. meat processing plant in London, Ontario have been linked to multiple outbreaks of Legionnaires' disease during the summers of 2024 and 2025.

Canada Healthcare

SL

Siskinds LLP

Bracing For PFAS: Implications For Businesses In The Face Of Increased Regulation

Across Canada, the federal and provincial governments continue to increase regulation of per- and polyfluoroalkyl substances ("PFAS") in tandem with scientific findings...

Canada Environment

ML

McMillan LLP

Panel Recap: Financing The Future Of Food – From IP To IPO

On May 20, 2025, MLT Aikins and the Canadian Food Innovation Network (CFIN) hosted Financing the future of food: from IP to IPO, a panel discussing the intricacies of intellectual property (IP)...

Canada Healthcare

MA

MLT Aikins LLP

Health Canada Releases Its Statistical Report 2024/2025 For PMNOC Regulations, Data Protection And CSPs

On July 25, 2025, the Office of Patented Medicines and Liaison of Health Canada released its Statistical Report 2024/2025 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection...

SB

Smart & Biggar

The Semaglutide Story: Highlighting The Need To Maintain Patent Protection In Canada

BC

Brunet & Co

Not All That Bubbles Is Champagne – Considerations For The Protection Of Geographical Indications In Canada

SB

Smart & Biggar

Turning Over A New Leaf? Federal Court Upholds Decision Of Trademarks Opposition Board On Non-distinctive And Confusion Grounds

D

Dentons Canada LLP

Naming Prescription Drugs: Navigating Regulatory And Trademark Challenges

ML

McMillan LLP

No Cherry Picking Here: Canadian Cherry Patent Victory In U.S. Agribusiness Intellectual Property Case

F

Fasken

CFIA Reinforces Accuracy In "Product Of Canada" And "Made In Canada" Claims

Canada Healthcare

MT

McCarthy Tétrault LLP

Health Canada To Modernize Biologic Drug Submissions

Canada Healthcare

TL

Torys LLP

Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques

MT

McCarthy Tétrault LLP

Important Changes To The Exception Patient Measure In Quebec

Canada Healthcare

F

Fasken

Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime

MT

McCarthy Tétrault LLP

Health Canada To Modernize Biologic Drug Submissions

Health Canada has made two announcements aimed at modernizing and streamlining submissions for biologic drugs, for both biosimilars and innovative biologic drugs.

Canada Healthcare

TL

Torys LLP

Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques

Le 25 juillet 2025, Santé Canada a publié son rapport statistique annuel 2024-2025 sur le Règlement sur les médicaments brevetés (avis de conformité), la protection des données et les certificats de protection supplémentaire.

MT

McCarthy Tétrault LLP

Important Changes To The Exception Patient Measure In Quebec

Important amendments to the Exception Patient Measure came into effect on June 2, 2025. A summary of the key changes is provided below.

Canada Healthcare

F

Fasken

Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime

On July 25, 2025, Health Canada released its annual 2024–2025 Statistical Report for the Patented Medicines (Notice of Compliance) Regulations, Data Protection...

MT

McCarthy Tétrault LLP

Patented Medicine Prices Review Board Publishes New Guidelines For PMPRB Staff: Finally, Some Guidance For Patentees

BL

Borden Ladner Gervais LLP

Important New Procedural Guidelines From The PMPRB

The Patented Medicine Prices Review Board (PMPRB) is a Canadian federal agency that regulates the prices of patented medicines in Canada.

AM

Aird & McBurney LP

Final Guidelines From Canada's PMPRB: The New Era Begins

On June 30, 2025, the PMPRB published final non-binding guidelines (Guidelines) titled Guidelines for PMPRB Staff: Administrative Process for Excessive Price Hearing Recommendation.

TL

Torys LLP

The Trademark Four(Mula): Enforcement And Risk Mitigation

Trademarks are important assets for any business. When it comes to trademark enforcement, options abound, which can sometimes be disorienting for the uninitiated.

OH

Osler, Hoskin & Harcourt LLP

Q&A On Managing Intergenerational Growth In Canadian Agribusiness

Canadian agricultural family enterprises are living legacies that anchor our local economies. From household names to community-driven farms, these businesses have deep...

Canada Real Estate

BJ

Bennett Jones LLP

July 2025 Rosen Sunshine Newsletter

Canada Government

RS

Rosen Sunshine LLP

Finalized PMPRB Guidelines Published

SB

Smart & Biggar

At Long Last: The New PMPRB Guidelines Are Here

Worldwide Healthcare

F

Fasken

CDA Opens Consultation On Proposed List Of Drugs To Inform Development Of National Formulary

Canada Healthcare

SB

Smart & Biggar

North Of Legal Or South Of Safe? Key Legal And Regulatory Considerations To Substantiate "Made In Canada" Claims

Canada Healthcare

LS

Lenczner Slaght LLP

CDA Opens Public Consultation On Pharmacare National Formulary – Deadline July 18, 2025

Canada Healthcare

F

Fasken

Health Canada's New Draft Guidance For Biosimilar Biologic Drugs

Canada Healthcare

F

Fasken

Health Canada Must Redetermine Exemption Requests For Psilocybin (Magic Mushroom)-Assisted Psychotherapy Training

Canada Healthcare

SB

Smart & Biggar

Pharma, National Security And Tariffs: Where Do We Go From Here?

Canada Healthcare

BL

Borden Ladner Gervais LLP

Psychedelic Appeal: FCA Rules That Government Must Explain Policy Change On Psilocybin Access

Canada Healthcare

TL

Torys LLP

Update On Biosimilars In Canada – June 2025

Canada Healthcare

SB

Smart & Biggar

Travel Insurance And Alcohol: What Every Canadian Needs To Know

Canada Litigation

Wallace Smith LLP

La nouvelle ébauche de la Ligne directrice de Santé Canada sur les médicaments biologiques biosimilaires

Canada Healthcare

FF

Fasken (French)

Health Canada Consultation On Revised Biosimilar Guidance: No Requirement For Comparative Clinical Efficacy And Safety Trials

Canada Healthcare

SB

Smart & Biggar

Legal Services For Buying Or Selling A Convenience Store In Canada

Canada Commercial

Pacific Legal PC

See more

Latest Videos

See more

Pricing And Reimbursement: Federal Drug Price Control

TL

Torys LLP

Nutrition Tips & Advice During COVID-19 (Video)

GW

Gowling WLG

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

Cannabis 2.0 Rollout: Edibles, Extracts Legalized (Video)

BC

Blake, Cassels & Graydon LLP

Emerging Growth And Venture Technology Video Series Part Seven: Tracking Ailments (Video)

D

Dentons Canada LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More